HH

Hayan Health Networks

North America, California, United States, San Francisco

Description

Hayan Health Networks is a healthcare and life science investment and management company.

Investor Profile

Hayan Health Networks has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (50%)
  • Seed (25%)
  • Series C (25%)

Country Focus

  • United States (75%)
  • Israel (25%)

Industry Focus

  • Biotechnology
  • Health Care
  • Biopharma
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hayan Health Networks frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
CRV
North America, California, United States, Palo Alto
Co-Investments: 1
Starlight Ventures
North America, Florida, United States, Miami
Co-Investments: 1
Thiel Capital
North America, California, United States, Los Angeles
Co-Investments: 2
Paladin Capital Group
North America, District of Columbia, United States, Washington
Co-Investments: 1
Third Point Ventures
North America, New York, United States, New York
Co-Investments: 1
OS Fund
North America, Illinois, United States, Chicago
Co-Investments: 1
Menlo Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Presight Capital
North America, California, United States, West Hollywood
Co-Investments: 1
Asset Management Ventures (AMV)
North America, California, United States, Palo Alto
Co-Investments: 1

Which angels does Hayan Health Networks often collaborate with?

SP
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Hayan Health Networks?

ImmPACT Bio

Camarillo, California, United States

ImmPACT Bio USA is developing novel cell therapies for treating cancer.

BiotechnologyLife Science
Series AAug 18, 2020
Amount Raised: $18,000,000
Chemomab

Tel Aviv, Tel Aviv, Israel

Chemomab is a clinical-stage biotech company focusing on the discovery and development of innovative therapeutics.

BiotechnologyHealth CarePharmaceutical
Series CDec 1, 2019
Amount Raised: $20,000,000
RubrYc Therapeutics

San Ramon, California, United States

RubrYc Therapeutics is a biotechnology company.

BiotechnologyHealth CareMedicalTherapeutics
Series AApr 11, 2018
Amount Raised: $10,000,000
3T Biosciences

Menlo Park, California, United States

3T Biosciences is an immunotherapy company headquartered in Menlo Park, California.

BiopharmaBiotechnologyHealth Care
SeedOct 4, 2017
Amount Raised: $12,000,000